Osimertinib Recruiting Phase 1 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Other

IndicationsStatusPurposePhase
RecruitingOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT03463525Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases